Pfizer — 360° view

Pfizer, a company in the Pharmaceuticals industry, reported revenue of ₹727 crore and net profit of ₹313 crore for the September 2026 quarter.

Pfizer (NSE: PFIZER) closed at ₹3,856.00 on 20 Nov 2026, down 23.3% over the past year. Its market capitalisation is ₹17,640 crore and it trades at 22.2 times earnings.

Share price
₹3,856.00 (20 Nov 2026)
Market cap
₹17,640 Cr (20 Nov 2026)
P/E
22.18 (20 Nov 2026)
Revenue
₹727 Cr (September 2026 quarter)
Net profit
₹313 Cr (September 2026 quarter)
ROCE
24.1% (FY26)
ROE
18.0% (FY26)
Book value
₹959 (FY26)
Dividend yield
1.95% (last 12 months to 20 Nov 2026)
52-week high / low
₹5,257.00 / ₹3,589.00 (20 Nov 2026)
1-year return
-23.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: PFIZER

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India. It is the 3rd largest multinational pharmaceutical company in India.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.